ENDRA Life Sciences (NDRA) vs Nexalin Technology (NXL)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
ENDRA Life Sciences is the larger company by market cap ($8.9 million vs $3.4 million), about 2.6 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Head-to-head
| Metric | NDRA | NXL |
|---|---|---|
| Share price | $5.91 | $4.09 |
| Market cap | $8.86M | $3.39M |
| 1-day change | -2.48% | -5.32% |
| EPS (TTM) | $-6.26 | $-14.10 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $9.85 | $50.70 |
| 52-week low | $2.96 | $3.98 |
| Distance from 52-week high | -40.00% | -91.93% |
| Average volume | 36.23K | 1.01M |
| Shares outstanding | 1.50M | 829.40K |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- ENDRA Life Sciences is about 2.6 times larger than Nexalin Technology by market value ($8.86M vs $3.39M).
NDRA vs NXL FAQ
Which is bigger, ENDRA Life Sciences or Nexalin Technology?
ENDRA Life Sciences (NDRA) is larger, with a market capitalization of $8.86M compared with $3.39M for Nexalin Technology (NXL).
Are ENDRA Life Sciences and Nexalin Technology in the same industry?
Yes. Both are classified in the Biotechnology: Electromedical & Electrotherapeutic Apparatus industry within the Health Care sector.